Tetratherix Limited

A$5.80As of Sun 8 Nov 2026, 12:00 UTC
ASX:TTXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (31.08%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM 34.57%
Mkt cap A$307.7M
ROIC (16.36%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$5.54
(4.42%)
271.66%
Hold 10|8|9|7|9
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.07
0.08
0.09
0.10
9.51%
16.02%
30.36%
36.25%
Revenue$M
16.85
17.13
17.93
18.81
13.39%
11.87%
12.07%
15.97%
Peers (US$211.4M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.954
0.049
0.049
EBIT/Intx
1.761
1.153
0.986
Own earn%
(6.08)
(106.67)
(102.76)
Sh yield%
48.47
42.16
40.41
Owners
Insiders/Inst%
14.94
55.95
Short interest%
3.45
SBC / revenue%
4.91
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
4–13
$1 testx
—
Incr. ROIC%
3